Total investments received (USD): 16.78m
Round value (USD): 6.43m
Company: Laminar Pharma
Industry:
Biotech
Health services


Netherlands
Austria
Germany
Switzerland
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
France
Ireland
Italy
Portugal
United Kingdom